Direct oral anticoagulants are effective and safe in the treatment of venous thromboembolism and atrial fibrillation in morbidly obese patients

J Thromb Thrombolysis. 2021 Apr;51(3):701-702. doi: 10.1007/s11239-020-02238-w.
No abstract available

Publication types

  • Letter

MeSH terms

  • Atrial Fibrillation* / complications
  • Atrial Fibrillation* / drug therapy
  • Body Mass Index
  • Factor Xa Inhibitors / administration & dosage
  • Factor Xa Inhibitors / adverse effects
  • Humans
  • Meta-Analysis as Topic
  • Obesity, Morbid* / complications
  • Obesity, Morbid* / diagnosis
  • Patient Selection
  • Rivaroxaban* / administration & dosage
  • Rivaroxaban* / adverse effects
  • Treatment Outcome
  • Venous Thromboembolism* / complications
  • Venous Thromboembolism* / prevention & control
  • Warfarin / administration & dosage
  • Warfarin / adverse effects

Substances

  • Factor Xa Inhibitors
  • Warfarin
  • Rivaroxaban